subsidiary

The Australian company incorporated the subsidiary as it plans for the US launch of its ResistancePlus MG assay.

The Singapore-based firm has established a US subsidiary and named distributors to sell its products across Europe, the Middle East, and Asia.

Sweden-based Immunovia is preparing to launch its first diagnostic — a liquid biopsy test for pancreatic cancer — in 2018.

The subsidiary is being formed in support of Biocartis' recent US distribution deal with Thermo Fisher Scientific.

Jason Terrell will lead the subsidiary, which will be based in Austin, Texas.